Found: 113
Select item for more details and to access through your institution.
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
- Published in:
- Diabetes Care, 2024, v. 47, n. 6, p. 1048, doi. 10.2337/dc24-0171
- By:
- Publication type:
- Article
An Insulin-Chromogranin A Hybrid Peptide Activates DR11-Restricted T Cells in Human Type 1 Diabetes.
- Published in:
- Diabetes, 2024, v. 73, n. 5, p. 743, doi. 10.2337/db23-0622
- By:
- Publication type:
- Article
Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function.
- Published in:
- Diabetes Care, 2023, v. 46, n. 10, p. 1848, doi. 10.2337/dc23-0675
- By:
- Publication type:
- Article
Measuring anti-islet autoimmunity in mouse and human by profiling peripheral blood antigen-specific CD4 T cells.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 703, p. 1, doi. 10.1126/scitranslmed.ade3614
- By:
- Publication type:
- Article
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.
- Published in:
- Diabetes Care, 2023, v. 46, n. 5, p. 1005, doi. 10.2337/dc22-2200
- By:
- Publication type:
- Article
Barriers to Screening: An Analysis of Factors Impacting Screening for Type 1 Diabetes Prevention Trials.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 3, p. 1, doi. 10.1210/jendso/bvad003
- By:
- Publication type:
- Article
Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 4, p. e1510, doi. 10.1210/clinem/dgab853
- By:
- Publication type:
- Article
Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample.
- Published in:
- Diabetologia, 2021, v. 64, n. 11, p. 2432, doi. 10.1007/s00125-021-05523-2
- By:
- Publication type:
- Article
Comparative study of efficiency and characteristics of FMT and DRT installed in human cadavers for round-window stimulation.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95456-y
- By:
- Publication type:
- Article
243-OR: Integrating Genetic Risk Score and Islet Autoantibody Characteristics in the Predictive Model for Type 1 Diabetes in the TrialNet Study.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-243-OR
- By:
- Publication type:
- Article
589-P: Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-589-P
- By:
- Publication type:
- Article
109-OR: T-Cell Responses to Hybrid Insulin Peptides Precede Type 1 Diabetes Development.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-109-OR
- By:
- Publication type:
- Article
12-OR: Metabolic Effects of Two Oral Insulin Dosing Regimens in Individuals at High Risk for Type 1 Diabetes (T1D).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-12-OR
- By:
- Publication type:
- Article
Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
- Published in:
- Diabetes, 2021, v. 70, n. 5, p. 1123, doi. 10.2337/db20-1103
- By:
- Publication type:
- Article
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 583, p. 1, doi. 10.1126/scitranslmed.abc8980
- By:
- Publication type:
- Article
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2045, doi. 10.1111/dom.14121
- By:
- Publication type:
- Article
247-OR: ADA Presidents' Select Abstract: Detection of T-Cells Reactive to Hybrid Insulin Peptides in Subjects at Risk for Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-247-OR
- By:
- Publication type:
- Article
1617-P: Association of High-Affinity Autoantibodies with High-Risk HLA Haplotypes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1617-P
- By:
- Publication type:
- Article
Risk of Islet and Celiac Autoimmunity in Cotwins of Probands With Type 1 Diabetes.
- Published in:
- Journal of the Endocrine Society, 2020, v. 4, n. 6, p. 1, doi. 10.1210/jendso/bvaa053
- By:
- Publication type:
- Article
Clinical trial data validate the C-peptide estimate model in type 1 diabetes.
- Published in:
- Diabetologia, 2020, v. 63, n. 4, p. 885, doi. 10.1007/s00125-020-05088-6
- By:
- Publication type:
- Article
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2020, v. 43, n. 1, p. 5, doi. 10.2337/dc19-0880
- By:
- Publication type:
- Article
Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 16, p. 3857, doi. 10.3390/ijms20163857
- By:
- Publication type:
- Article
1669-P: Proinsulin: C-Peptide Ratios in Relatives of Persons with Type 1 Diabetes.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1669-P
- By:
- Publication type:
- Article
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biomarker discovery in pre-Type 1 Diabetes; Th40 cells as a predictive risk factor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 655, doi. 10.1007/s00125-018-4786-9
- By:
- Publication type:
- Article
Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02332
- By:
- Publication type:
- Article
Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Learning From Past Failures of Oral Insulin Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Loss of B-Cell Anergy in Type 1 Diabetes Is Associated With High-Risk HLA and Non-HLA Disease Susceptibility Alleles.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combinatorial detection of autoreactive CD8<sup>+</sup> T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 658, doi. 10.1007/s00125-017-4508-8
- By:
- Publication type:
- Article
Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Understanding and preventing type 1 diabetes through the unique working model of TrialNet.
- Published in:
- Diabetologia, 2017, v. 60, n. 11, p. 2139, doi. 10.1007/s00125-017-4384-2
- By:
- Publication type:
- Article
Impact of Age and Antibody Type on Progression From Single to Multiple Autoantibodies in Type 1 Diabetes Relatives.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predominance of DR3 in Somali children with type 1 diabetes in the twin cities, Minnesota.
- Published in:
- Pediatric Diabetes, 2017, v. 18, n. 2, p. 136, doi. 10.1111/pedi.12369
- By:
- Publication type:
- Article
Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
First results of a novel adjustable-length ossicular reconstruction prosthesis in temporal bones.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.
- Published in:
- Current Diabetes Reports, 2016, v. 16, n. 10, p. 1, doi. 10.1007/s11892-016-0793-8
- By:
- Publication type:
- Article
Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial.
- Published in:
- Diabetologia, 2016, v. 59, n. 6, p. 1153, doi. 10.1007/s00125-016-3917-4
- By:
- Publication type:
- Article
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.
- Published in:
- 2015
- By:
- Publication type:
- journal article